PLACEBO SOTAGLIFLOZIN, SOTAGLIFLOZIN
LX4211.1-314-HCM
Phase 3 small_molecule active
Quick answer
PLACEBO SOTAGLIFLOZIN, SOTAGLIFLOZIN for Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy is a Phase 3 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LEXICON PHARMACEUTICALS, INC.
- Indication
- Obstructive Cardiomyopathy, Hypertrophic, Non-obstructive Hypertrophic Cardiomyopathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active